Global Endocrinology Drugs Market 2016-2020

SKU ID : TNV- 10278756

Publishing Date : 19-Apr-2016

No. of pages : 118

PRICE
2500
4000

  • About Endocrinology Drugs

    Endocrinology deals with the study of the endocrine system, including the biochemical and physiological functions of the hormones, cells, and tissues of the endocrine glands. Endocrine disorders can be broadly subdivided into three categories: endocrine gland hyposecretion, which causes hormone deficiency, endocrine gland hypersecretion, which causes excess hormone secretion, and tumors in the endocrine gland. The endocrine disorders considered for the present report include diabetes, human growth hormone deficiency, thyroid disorders, and male hypogonadism.


    Technavio’s analysts forecast the global endocrinology drugs market to grow at a CAGR of 6.69% during the period 2016-2020.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global endocrinology drugs market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics, and biosimilars used to treat and prevent type 1 and type 2 diabetes, human growth hormone deficiency, hypogonadism, and thyroid gland disorders.

    The market is divided into the following segments based on geography:
    • Americas
    • APAC
    • EMEA

    Technavio's report, Global Endocrinology Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • AbbVie Inc.
    • AstraZeneca PLC
    • Eli Lilly and Co.
    • Merck & Co
    • Novo Nordisk AS
    • Sanofi SA

    Other prominent vendors
    • Acerus Pharmaceuticals
    • Acrux DDS
    • Adocia
    • Æterna Zentaris
    • Akros Pharma
    • Allergan
    • Amgen
    • Antares Pharma
    • Ascendis Pharma
    • Astellas Pharma
    • Baxalta
    • Bayer HealthCare Pharmaceuticals
    • BHV Pharma
    • Biocon
    • Biodel
    • Boehringer Ingelheim
    • ChipScreen Biosciences
    • Clarus Therapeutics
    • ConjuChem
    • Critical Pharmaceuticals
    • CureDm
    • CymaBay Therapeutics
    • Daiichi Sankyo
    • Dance Biopharm
    • DiaMedica
    • Diamyd Therapeutics
    • Diasome Pharmaceuticals
    • DiaVacs
    • Dong-A ST
    • Eisai
    • Elcelyx Therapeutics
    • Endo Pharmaceuticals
    • Exsulin
    • Ferring Pharmaceuticals
    • Gan & Lee Pharmaceuticals
    • Genentech
    • Generex
    • Genexine
    • Genfit
    • GSK
    • HanAll BioPharma
    • Hanmi Pharmaceutical
    • Hua Medicine
    • ILTOO Pharma
    • Intarcia Therapeutics
    • InteKrin Therapeutics
    • Intrexon
    • Ionis Pharmaceuticals
    • Ipe
    • Islet Sciences
    • Janssen Pharmaceuticals
    • Japan Tobacco
    • Juniper Pharmaceuticals
    • Kadmon Corporation
    • Kamada
    • KinDex Pharmaceuticals
    • Kissei Pharmaceutical
    • Kotobuki
    • Lexicon Pharmaceuticals
    • LG Life Sciences
    • Ligand Pharmaceuticals
    • Lipocine
    • Living Cell Technologies
    • MacroGenics
    • MannKind
    • MedImmune
    • Melior Pharmaceuticals
    • Metabolic Solutions Development Company
    • MetP Pharma
    • Mitsubishi Tanabe Pharma
    • Mylan
    • NGM Biopharmaceuticals
    • Novartis
    • NuSirt Biopharma
    • OPKO Biologics
    • Oramed Pharmaceuticals
    • Osiris Therapeutics
    • Peptron
    • Perle Biosciences
    • Pfizer
    • PhaseBio Pharmaceuticals
    • Poxel
    • ProStrakan Group
    • REGiMMUNE
    • Repros Therapeutics
    • Roche
    • Sanwa Kagaku Kenkyusho
    • Sirona Biochem
    • Strongbridge Biopharma
    • Takeda Pharmaceuticals
    • TesoRx Pharma
    • Teva Pharmaceutical
    • Theracos
    • Theratechnologies
    • Toleranzia
    • Tolerion
    • Transition Therapeutics
    • VeroScience
    • Versartis
    • vTv Therapeutics
    • XBiotech
    • Xeris Pharmaceuticals
    • XOMA

    Market driver
    • Increase in prevalence of endocrine hormone-related diseases
    • For a full, detailed list, view our report

    Market challenge
    • Generic erosion
    • For a full, detailed list, view our report

    Market trend
    • Increase in outsourcing
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2020 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports